Jpmorgan Chase & Co »

In8bio shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of In8bio (INAB) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in In8bio

Tip: Access up to 7 years of quarterly data

All positions including In8bio held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in In8bio by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2024-09-30 $23 85 0.27
2024-06-30 $66 78 0.85
2024-03-31 $80 69 1.17
2023-12-31 $47 34 1.38
2023-09-30 $19 18 1.06

More positions owned by Jpmorgan Chase & Co

Microsoft Corp Common (MSFT)
Nvidia Corporation Common (NVDA)
Apple Common (AAPL)
Amazon Common (AMZN)
Spdr S&p 500 Etf Ser 1 S&p Common (SPY)
Meta Platforms Common (META)
Eli Lilly & Co Common (LLY)
Alphabet Common (GOOG)
Unitedhealth Group Common (UNH)
Mastercard Incorporated Common (MA)
Vanguard Index Fds S&p 500 Etf Common (VOO)
Ishares Core S&p 500 Etf Fund (IVV)
Vanguard Total Intl Bond Etf Fund (BNDX)
Broadcom Common (AVGO)
Exxon Mobil Corp Common (XOM)

View all positions for Jpmorgan Chase & Co

Top funds holding In8bio

AIGH Capital Management
Vanguard Group
683 Capital Management
Sigma Planning
Ensign Peak Advisors
Alyeska Investment Group
Geode Capital Management
Stonegate Investment Group
Bridgeway Capital Management
State Street Corporation
Texas Capital Bank Wealth Management Services
Two Sigma Securities
Voss Capital
BlackRock
BlackRock

View all funds holding In8bio